PGR vs TERN · P/E 10, rev $87.67B vs $6.12B cap
Progressive Corp (PGR) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PGR currently screens at market cap $119.28B and trailing P/E 10.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PGR and TERN stock pages for the full models.
Not investment advice.